How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

A merge sort uses smaller, ordered lists which are easier to sort and merge than larger lists. It is usually more efficient and quicker than the bubble sort. It is more complex to code. It will still ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

20+ Years of Bubble Magic. 18 Guinness Records. One Unforgettable Experience.